Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ENCUBE

  • FDA Approval
  • Dec. 18, 2024, 09:43 UTC
  • 31
  • 0 comments

FDA approve NITROGLYCERIN

Comment Full text

PYRAMID PHARM

  • FDA Approval
  • Dec. 18, 2024, 09:43 UTC
  • 35
  • 0 comments

FDA approve METHADONE HYDROCHLORIDE

Comment Full text

CHARTWELL MOLECULES

  • FDA Approval
  • Dec. 18, 2024, 09:43 UTC
  • 33
  • 0 comments

FDA approve ONDANSETRON

Comment Full text

DEXCEL

  • FDA Approval
  • Dec. 18, 2024, 09:43 UTC
  • 36
  • 0 comments

FDA approve TOFACITINIB CITRATE

Comment Full text

PFIZER

  • FDA Approval
  • Dec. 18, 2024, 09:43 UTC
  • 34
  • 0 comments

FDA approve CEFOPERAZONE SODIUM

Comment Full text

COSETTE

  • FDA Approval
  • Dec. 18, 2024, 09:43 UTC
  • 32
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text

SUN PHARM

  • FDA Approval
  • Dec. 18, 2024, 09:43 UTC
  • 35
  • 0 comments

FDA approve DEFERASIROX

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • Dec. 18, 2024, 09:43 UTC
  • 33
  • 0 comments

FDA approve DIAZEPAM

Comment Full text

CELLTRION, INC.

  • FDA Approval
  • Dec. 17, 2024, 22:30 UTC
  • 32
  • 0 comments

FDA approve USTEKINUMAB-STBA

Comment Full text

NOVARTIS PHARMS

  • FDA Approval
  • Dec. 17, 2024, 20:18 UTC
  • 40
  • 0 comments

FDA approve LETROZOLE

Comment Full text
  • Previous
  • 177
  • 178
  • 179
  • 180
  • 181
  • Next

Search

News categories

  • Technical Exchange News(9877)
  • Event(407)
  • SEC News(167276)
  • FDA Approval(9337)
  • Company Report(721)
  • Business News(111103)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin